226 related articles for article (PubMed ID: 27660157)
1. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.
Kobyliak N; Falalyeyeva T; Bodnar P; Beregova T
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):123-130. PubMed ID: 27660157
[TBL] [Abstract][Full Text] [Related]
2. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease.
Kobyliak N; Abenavoli L; Falalyeyeva T; Beregova T
Ann Hepatol; 2018; 17(1):153-161. PubMed ID: 29311399
[TBL] [Abstract][Full Text] [Related]
4. Probiotics and nutraceuticals as a new frontier in obesity prevention and management.
Kobyliak N; Falalyeyeva T; Boyko N; Tsyryuk O; Beregova T; Ostapchenko L
Diabetes Res Clin Pract; 2018 Jul; 141():190-199. PubMed ID: 29772287
[TBL] [Abstract][Full Text] [Related]
5. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.
Savcheniuk O; Kobyliak N; Kondro M; Virchenko O; Falalyeyeva T; Beregova T
BMC Complement Altern Med; 2014 Jul; 14():247. PubMed ID: 25030027
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study.
Kobyliak N; Abenavoli L; Falalyeyeva T; Mykhalchyshyn G; Boccuto L; Kononenko L; Kyriienko D; Komisarenko I; Dynnyk O
Minerva Med; 2018 Dec; 109(6):418-428. PubMed ID: 30221912
[TBL] [Abstract][Full Text] [Related]
7. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition.
Kobyliak N; Falalyeyeva T; Beregova T; Spivak M
Endokrynol Pol; 2017; 68(6):659-667. PubMed ID: 29022648
[TBL] [Abstract][Full Text] [Related]
8. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.
Al-Muzafar HM; Amin KA
BMC Complement Altern Med; 2017 Jan; 17(1):43. PubMed ID: 28086768
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
Alwayn IP; Gura K; Nosé V; Zausche B; Javid P; Garza J; Verbesey J; Voss S; Ollero M; Andersson C; Bistrian B; Folkman J; Puder M
Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
[TBL] [Abstract][Full Text] [Related]
10. Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.
Coelho CFF; França LM; Nascimento JR; Dos Santos AM; Azevedo-Santos APS; Nascimento FRF; Paes AMA
J Dev Orig Health Dis; 2019 Apr; 10(2):188-195. PubMed ID: 29855396
[TBL] [Abstract][Full Text] [Related]
11. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
[TBL] [Abstract][Full Text] [Related]
13. Effects of polyphenol compounds melanin on NAFLD/NASH prevention.
Belemets N; Kobyliak N; Virchenko O; Falalyeyeva T; Olena T; Bodnar P; Savchuk O; Galenova T; Caprnda M; Rodrigo L; Skladany L; Delev D; Opatrilova R; Kruzliak P; Beregova T; Ostapchenko L
Biomed Pharmacother; 2017 Apr; 88():267-276. PubMed ID: 28110193
[TBL] [Abstract][Full Text] [Related]
14. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
15. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine.
Bonfleur ML; Borck PC; Ribeiro RA; Caetano LC; Soares GM; Carneiro EM; Balbo SL
Life Sci; 2015 Aug; 135():15-21. PubMed ID: 26092479
[TBL] [Abstract][Full Text] [Related]
16. Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD).
Castro RQ; Soto Rodriguez I; Deschamps Lago RA; Pagola PG; Rodriguez Antolin J; Peres Quintal A; Rivera JR; Aguilera AA
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Jun; 162(2):99-106. PubMed ID: 29765172
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis.
Kabel AM; Abd Elmaaboud MA; Albarraq AA
Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():1-9. PubMed ID: 25541279
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
[TBL] [Abstract][Full Text] [Related]
19. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
20. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model.
Marsman HA; Heger M; Kloek JJ; Nienhuis SL; van Werven JR; Nederveen AJ; Ten Kate FJ; Stoker J; van Gulik TM
J Gastroenterol Hepatol; 2011 Feb; 26(2):356-63. PubMed ID: 21261727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
